Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by J.H. Whitney Equity Partners VII LLC

J.H. Whitney Equity Partners VII LLC cut its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 20.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,242,631 shares of the company’s stock after selling 9,597,968 shares during the period. Aveanna Healthcare makes up about 100.0% of J.H. Whitney Equity Partners VII LLC’s investment portfolio, making the stock its largest holding. J.H. Whitney Equity Partners VII LLC owned about 0.17% of Aveanna Healthcare worth $296,103,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in AVAH. AQR Capital Management LLC boosted its position in shares of Aveanna Healthcare by 21.2% during the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after buying an additional 4,602 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Aveanna Healthcare by 8.3% during the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after buying an additional 25,974 shares during the period. Jane Street Group LLC boosted its position in shares of Aveanna Healthcare by 522.0% during the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after buying an additional 63,010 shares during the period. Creative Planning boosted its position in shares of Aveanna Healthcare by 15.1% during the second quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after buying an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Aveanna Healthcare by 65.0% during the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after buying an additional 62,348 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Patrick A. Cunningham sold 125,000 shares of the stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the completion of the sale, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. This represents a 37.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $36,455,577.60. Following the sale, the insider owned 13,450,547 shares of the company’s stock, valued at $83,931,413.28. This trade represents a 30.28% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 19,967,240 shares of company stock worth $124,764,328 over the last quarter. 5.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on AVAH shares. Barclays reduced their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. BMO Capital Markets reduced their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Truist Financial boosted their price objective on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday. Finally, Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a research report on Friday, March 20th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $10.50.

Aveanna Healthcare Stock Performance

Shares of AVAH opened at $6.68 on Friday. The firm’s 50 day moving average is $6.79 and its 200-day moving average is $7.72. The stock has a market capitalization of $1.45 billion, a P/E ratio of 5.66, a P/E/G ratio of 0.74 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.73 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The company had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. The company’s quarterly revenue was up 15.9% compared to the same quarter last year. Equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.